Acute Kidney Injury Clinical Trials in Cleveland, Ohio

5 studies are recruiting for acute kidney injury in Cleveland, Ohio right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury

   This randomized, controlled, pivotal study is intended to determine whether up to ten sequential 24-hour treatments with the Selective Cytopheretic Device (SCD) will improve survival in patients with Acute Kidney Injury (AKI) requiring continuous kidney replacement therapy (CKRT) when compared to C…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Cleveland Clinic, Cleveland, Ohio

   Locations

   36 in total

   Run by

   SeaStar Medical

   See if you can join NCT05758077 on ClinicalTrials.gov

2. A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI Trial

   The COPE-AKI study is a randomized, pragmatic, parallel-arm trial comparing a multimodal intervention to usual care on hospital-free days through 90 days of study follow up. The primary study hypothesis is that patients randomized to the intervention will have increased odds of more hospital-free d…

   Stage

   Not phased

   Ages

   18 and older

   Site

   MetroHealth, Cleveland, Ohio

   Locations

   9 in total

   Run by

   University of Pittsburgh

   See if you can join NCT05805709 on ClinicalTrials.gov

3. CTSN Embolic Protection Trial

   This is a prospective, multi-center, randomized effectiveness trial of the CardioGard Embolic Protection Cannula in high-risk valve surgery patients.

   Stage

   Not phased

   Ages

   60 and older

   Site

   Cleveland Clinic, Cleveland, Ohio

   Locations

   28 in total

   Run by

   Icahn School of Medicine at Mount Sinai

   See if you can join NCT06027788 on ClinicalTrials.gov

4. QUELIMMUNE (SCD-PED) PediAtric SurVeillance REgistry

   QUELIMMUNE is FDA-approved under an HDE for the treatment of pediatric patients (weight ≥10kg and age ≤22 years) with AKI due to sepsis or a septic condition on antibiotic therapy and requiring RRT. The purpose of this surveillance registry is to prospectively collect safety data among all patients…

   Stage

   Not phased

   Ages

   Up to 22

   Site

   Cleveland Clinic Children's Hospital, Cleveland, Ohio

   Locations

   15 in total

   Run by

   SeaStar Medical

   See if you can join NCT06517810 on ClinicalTrials.gov

5. Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry

   The Accuryn Registry Study is an open-ended, global, multi-center, retrospective and prospective, single-arm data collection study with an FDA cleared device. The target population are cardiovascular surgery patients. Physiologic data measurements will be collected from enrolled subjects using elec…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Cleveland Clinic, Cleveland, Ohio

   Locations

   9 in total

   Run by

   Potrero Medical

   See if you can join NCT04669548 on ClinicalTrials.gov